linea guida aiom - terapia del dolore in oncologia - Azienda USL di ...
linea guida aiom - terapia del dolore in oncologia - Azienda USL di ...
linea guida aiom - terapia del dolore in oncologia - Azienda USL di ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Bibliografia<br />
1. World Health Organization: Cancer pa<strong>in</strong> relief. World Health Organization, Geneva, 1986<br />
2. Tass<strong>in</strong>ari D, Sartori S, Tambur<strong>in</strong>i E, et al. Adverse effects of transdermal opiates treat<strong>in</strong>g<br />
moderate-severe pa<strong>in</strong> <strong>in</strong> comparison to long-act<strong>in</strong>g morph<strong>in</strong>e: a meta-analysis and<br />
systematic review of the literature. J Palliat Med 2008; 11: 492-501<br />
3. WHO normative gui<strong>del</strong><strong>in</strong>es on pa<strong>in</strong> management: report of a <strong>del</strong>phi study to determ<strong>in</strong>e the<br />
need for gui<strong>del</strong><strong>in</strong>es and to identify the number and topics of gui<strong>del</strong><strong>in</strong>es that should be<br />
developed by who. Geneva june 2007<br />
4. Mar<strong>in</strong>angeli F, Ciccozzi A, Leonar<strong>di</strong>s M, et al. Use of strong opioids <strong>in</strong> advanced cancer<br />
pa<strong>in</strong>: a randomized study. J Pa<strong>in</strong> Symptom Manage. 2004; 27:409-416<br />
5. Maltoni M, Scarpi E, Modenesi C, et al. A validation study of the WHO analgesic ladder: a<br />
two-step vs three-step strategy. Support Care Cancer 2005; 13: 888-894<br />
6. Ashby MA, Flem<strong>in</strong>g BG, Brooksbank M, et al. Description of a mechanistic approach to<br />
pa<strong>in</strong> management <strong>in</strong> advanced cancer. Prelim<strong>in</strong>ary report. Pa<strong>in</strong> 1992; 51:153-161<br />
7. Meuser T, Pietruck C, Radbruch L, et al: Symptoms dur<strong>in</strong>g cancer pa<strong>in</strong> treatment<br />
follow<strong>in</strong>g who-gui<strong>del</strong><strong>in</strong>es: a longitud<strong>in</strong>al follow-up study of symptom prevalence, severity<br />
and etiology. Pa<strong>in</strong> 2001; 93: 247-257<br />
8. Mercadante S, Bruera E: Opioid switch<strong>in</strong>g: a systematic and critical review. Curr Treat<br />
Rev 200: 304-315<br />
Figura 2. La scala analgesica OMS a tre grad<strong>in</strong>i nella sua formulazione orig<strong>in</strong>ale<br />
29